SU1072809A3 - Способ получени тиадиазолтетрагидроизохинолина или его фармацевтически приемлемой кислотно-аддитивной соли - Google Patents

Способ получени тиадиазолтетрагидроизохинолина или его фармацевтически приемлемой кислотно-аддитивной соли Download PDF

Info

Publication number
SU1072809A3
SU1072809A3 SU802942953A SU2942953A SU1072809A3 SU 1072809 A3 SU1072809 A3 SU 1072809A3 SU 802942953 A SU802942953 A SU 802942953A SU 2942953 A SU2942953 A SU 2942953A SU 1072809 A3 SU1072809 A3 SU 1072809A3
Authority
SU
USSR - Soviet Union
Prior art keywords
acceptable acid
pharmaceutically acceptable
acid addition
thiadiazoletetrahydroisoquinonoline
preparing
Prior art date
Application number
SU802942953A
Other languages
English (en)
Russian (ru)
Inventor
Эдвард Бондинелл Виллям
Роберт Джирард Джеральд
Original Assignee
Смитклайн Бэкмэн Корпорейшн (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бэкмэн Корпорейшн (Фирма) filed Critical Смитклайн Бэкмэн Корпорейшн (Фирма)
Application granted granted Critical
Publication of SU1072809A3 publication Critical patent/SU1072809A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SU802942953A 1979-07-02 1980-07-01 Способ получени тиадиазолтетрагидроизохинолина или его фармацевтически приемлемой кислотно-аддитивной соли SU1072809A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5434379A 1979-07-02 1979-07-02

Publications (1)

Publication Number Publication Date
SU1072809A3 true SU1072809A3 (ru) 1984-02-07

Family

ID=21990408

Family Applications (1)

Application Number Title Priority Date Filing Date
SU802942953A SU1072809A3 (ru) 1979-07-02 1980-07-01 Способ получени тиадиазолтетрагидроизохинолина или его фармацевтически приемлемой кислотно-аддитивной соли

Country Status (30)

Country Link
EP (1) EP0023761B1 (es)
JP (1) JPS5610192A (es)
KR (1) KR840000396B1 (es)
AR (1) AR225925A1 (es)
AT (1) ATE6515T1 (es)
AU (1) AU531641B2 (es)
BG (1) BG51250A3 (es)
CA (1) CA1129415A (es)
CS (1) CS215064B2 (es)
DD (1) DD151750A5 (es)
DE (1) DE3066826D1 (es)
DK (1) DK151029C (es)
ES (1) ES492971A0 (es)
FI (1) FI67221C (es)
GR (1) GR69206B (es)
HU (1) HU179382B (es)
IE (1) IE50290B1 (es)
IL (1) IL60426A (es)
IN (1) IN160542B (es)
MX (1) MX6317E (es)
NO (1) NO801951L (es)
NZ (1) NZ194156A (es)
PH (1) PH17042A (es)
PL (2) PL127098B1 (es)
PT (1) PT71458A (es)
RO (1) RO79707A (es)
SU (1) SU1072809A3 (es)
YU (1) YU171180A (es)
ZA (1) ZA802987B (es)
ZW (1) ZW14680A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352809A (en) * 1981-09-04 1982-10-05 Smithkline Corporation Method of producing alpha2 antagonism

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3939164A (en) * 1974-02-08 1976-02-17 Smithkline Corporation 7 AND 8-Halo substituted 1,2,3,4-tetrahydroisoquinoline compounds
US3988339A (en) * 1974-02-08 1976-10-26 Smithkline Corporation Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1. Гетероциклические соединени . Под ред. Р.Эльдерфильда. М., , 1965, т.7., с.421. *

Also Published As

Publication number Publication date
ZA802987B (en) 1981-05-27
ES8105736A1 (es) 1981-06-01
MX6317E (es) 1985-04-01
FI67221C (fi) 1985-02-11
YU171180A (en) 1983-09-30
DK151029B (da) 1987-10-12
JPS5610192A (en) 1981-02-02
PL225377A1 (es) 1981-08-21
BG51250A3 (en) 1993-03-15
AU531641B2 (en) 1983-09-01
FI802112A (fi) 1981-01-03
EP0023761A1 (en) 1981-02-11
DK274280A (da) 1981-01-03
EP0023761B1 (en) 1984-03-07
PH17042A (en) 1984-05-17
AR225925A1 (es) 1982-05-14
CS215064B2 (en) 1982-07-30
DE3066826D1 (en) 1984-04-12
PL230619A1 (es) 1981-12-11
NO801951L (no) 1981-01-05
IN160542B (es) 1987-07-18
FI67221B (fi) 1984-10-31
IL60426A (en) 1984-03-30
DD151750A5 (de) 1981-11-04
NZ194156A (en) 1983-03-15
ZW14680A1 (en) 1980-09-24
HU179382B (en) 1982-10-28
IL60426A0 (en) 1980-09-16
KR830002791A (ko) 1983-05-30
DK151029C (da) 1988-03-07
RO79707A (ro) 1982-08-17
ATE6515T1 (de) 1984-03-15
PT71458A (en) 1980-07-01
ES492971A0 (es) 1981-06-01
KR840000396B1 (ko) 1984-03-30
GR69206B (es) 1982-05-07
AU5967780A (en) 1981-01-15
IE50290B1 (en) 1986-03-19
CA1129415A (en) 1982-08-10
PL127098B1 (en) 1983-09-30
IE801352L (en) 1981-01-02

Similar Documents

Publication Publication Date Title
SU820659A3 (ru) Способ получени производных 4-амино- 5-АлКилСульфОНилОАНизАМидОВ, иХ СОлЕй,ОКиСЕй, лЕВО- и пРАВОВРАщАющиХизОМЕРОВ /иХ ВАРиАНТы/
US4182774A (en) Method of inhibiting blood platelet aggregation with 2-amino-3-(5- and 6-)benzoylphenylacetic acids, esters and metal salts thereof
RU2049771C1 (ru) Хиноновые производные и их фармакологически приемлемые соли
JPH02104526A (ja) 高血圧症治療用組成物
EP0047536B1 (en) Substituted propylamines
US4214089A (en) Thiazolo[3,2-a]benzimidazoles, imidazo [2,1-b]thiazoles, and related compounds as antineoplastic agents, and enhancers of the immune response
CS202066B2 (en) Method of preparing alpha-amino-phophonic acids
EP0173520B1 (en) Tricyclic oxindole antiinflammatory agents
IL30782A (en) Amino guanidines
US4249021A (en) Indanacetic acid compounds
US4128666A (en) 4 AND 5-Halo substituted 2-indanamine compounds
SU1072809A3 (ru) Способ получени тиадиазолтетрагидроизохинолина или его фармацевтически приемлемой кислотно-аддитивной соли
US3923994A (en) Anti-arthritic compositions comprising a 3-aryl 2-thiohydantoin and methods of producing anti-arthritic acitvity
US4091105A (en) 2-Imino-3-aminothiazolidines and indoleamine-N-methyltransferase inhibition
US4304785A (en) Dilignols and dilignol-type compounds
AU600480B2 (en) Ester prodrugs of dopamine-beta-hydroxylase inhibitors
JPH01250316A (ja) 抗脂血剤
CA2204007A1 (en) Remedy for diseases caused by infection with helicobacter
US4242346A (en) Bis-2N-alkylene tetrahydroisoquinoline compounds
US3962438A (en) Anti-arthritic 1H-pyrimido-(5,4,3-kl)phenothiazine-1,3(2H)-diones and 1-thiones
US3005818A (en) 1-phenyl-2, 3-dimethyl-4-morpholino methyl pyrazolone-(5) compounds
US4307091A (en) Process for treatment of allergic conditions with benzoxazinediones
US4258049A (en) Inhibiting phenylethanolamine N-methyltransferase with thiadiazolo and oxadiazolotetrahydroisoquinolines
US4272531A (en) 3,3'-Bis-methylene-1,3-benzo-thiazine compounds
SU1447283A3 (ru) Способ получени конденсированных производных @ S-триазина